Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vincent Aurentz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sands Capital Life Sciences Pulse Fund II, L.P. - $3.00M in IKT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vincent Aurentz?
Vincent Aurentz is a corporate insider of Inhibikase Therapeutics, Inc. (IKT). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Vincent Aurentz last file a Form 4?
The most recent primary Form 4 on record is dated 30 June 2026, one of 5 filings going back to 2024.
